Form 8-K - Current report:
SEC Accession No. 0001193125-25-053462
Filing Date
2025-03-13
Accepted
2025-03-13 06:54:13
Documents
16
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d926314d8k.htm   iXBRL 8-K 39077
2 EX-99.1 d926314dex991.htm EX-99.1 335911
3 EX-99.2 d926314dex992.htm EX-99.2 55091
7 GRAPHIC g926314g0313095023211.jpg GRAPHIC 2623
  Complete submission text file 0001193125-25-053462.txt   593398

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ndoi-20250313.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndoi-20250313_lab.xml EX-101.LAB 15198
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndoi-20250313_pre.xml EX-101.PRE 9537
18 EXTRACTED XBRL INSTANCE DOCUMENT d926314d8k_htm.xml XML 3107
Mailing Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 25733794
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)